J. Molner Stock

MOLNRIPO

EE3100109034

Pharmaceuticals

Delayed Nasdaq Tallinn Other stock markets 07:55:44 2024-04-30 am EDT			5-day change	1st Jan Change
15.1 ^EUR	+3.42%		+0.67%	+9.82%

Mar. 04	J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	CI
2023	Certain Ordinary Shares of J. Molner AS are subject to a Lock-Up Agreement Ending on 7-NOV-2023.	CI

Latest news about J. Molner

J. Molner AS Enters into an Agreement with the US Centers for Medicaid and Medicare Services	Mar. 04	CI
Certain Ordinary Shares of J. Molner AS are subject to a Lock-Up Agreement Ending on 7-NOV-2023.	Nov. 06	CI
J. Molner AS Signs Licensing Agreement for Five Approved Drugs in the US	23-09-06	CI
J. Molner AS has completed an IPO in the amount of Ã‡1.199998 million.	22-11-07	CI
J. Molner AS has filed an IPO in the amount of Ã‡1.199998 million.	22-10-12	CI

More news

Highs and lows

1 week

14.20

15.10

1 month

14.20

16.00

Current year

12.80

18.00

1 year

5.10

18.00

3 years

5.00

18.00

5 years

5.00

18.00

10 years

5.00

18.00

More quotes

JMolner AS is an Estonia-based company primarily engaged in generic drug development for specialty generic pharmaceuticals. The Company also provides analytical chemistry services and cost-saving commercial stability solutions. The Company's main focus is on the USA and Canadian markets, however it also provides its laboratory analytics services to local Estonian and European customers.

Sector

Pharmaceuticals

Calendar

2024-08-04 - Q2 2024 Earnings Release (Projected)

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
J. MOLNER	+9.82%	27.22M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.27%	43.18B
OTSUKA HOLDINGS CO., LTD.	+24.05%	23.23B
SANDOZ GROUP AG	+15.11%	14.6B
CIPLA LIMITED	+12.33%	13.54B
ZYDUS LIFESCIENCES LIMITED	+38.36%	11.5B
ONO PHARMACEUTICAL CO., LTD.	-7.63%	6.79B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+10.21%	5.31B